185 related articles for article (PubMed ID: 22659796)
1. Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells.
Pan J; Chen C; Jin Y; Fuentes-Mattei E; Velazquez-Tores G; Benito JM; Konopleva M; Andreeff M; Lee MH; Yeung SC
Cell Cycle; 2012 Jun; 11(12):2314-26. PubMed ID: 22659796
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemia.
Vu K; Busaidy N; Cabanillas ME; Konopleva M; Faderl S; Thomas DA; O'Brien S; Broglio K; Ensor J; Escalante C; Andreeff M; Kantarjian H; Lavis V; Yeung SC
Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):355-62. PubMed ID: 22658895
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Insulin-mediated Regulation of AKT Signaling in Childhood Acute Lymphoblastic Leukemia.
Wang J; Xue HM; Chen YR; Xu HG; Lin SF; Tang XK; Chen C
J Pediatr Hematol Oncol; 2019 Mar; 41(2):96-104. PubMed ID: 30688831
[TBL] [Abstract][Full Text] [Related]
4. The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth.
Feng YH; Velazquez-Torres G; Gully C; Chen J; Lee MH; Yeung SC
J Cell Mol Med; 2011 Apr; 15(4):825-36. PubMed ID: 20455996
[TBL] [Abstract][Full Text] [Related]
5. Metformin induces apoptosis through AMPK-dependent inhibition of UPR signaling in ALL lymphoblasts.
Leclerc GM; Leclerc GJ; Kuznetsov JN; DeSalvo J; Barredo JC
PLoS One; 2013; 8(8):e74420. PubMed ID: 24009772
[TBL] [Abstract][Full Text] [Related]
6. Effects of first-line diabetes therapy with biguanides, sulphonylurea and thiazolidinediones on the differentiation, proliferation and apoptosis of islet cell populations.
Sarnobat D; Moffett RC; Flatt PR; Tarasov AI
J Endocrinol Invest; 2022 Jan; 45(1):95-103. PubMed ID: 34191257
[TBL] [Abstract][Full Text] [Related]
7. The antileukemia roles of PP242 alone or in combination with daunorubicin in acute leukemia.
Shi F; Yang X; Gong Y; Shi R; Yang X; Naren D; Wu J
Anticancer Drugs; 2015 Apr; 26(4):410-21. PubMed ID: 25535978
[TBL] [Abstract][Full Text] [Related]
8. Disruption of the Hippo pathway promotes the proliferation of childhood acute lymphoblastic leukemia cells, inhibits apoptosis and chemosensitivity.
Jiang H; Zhang RB; Peng J; Ren L; Wang HD
Expert Rev Hematol; 2024 Jun; 17(6):269-274. PubMed ID: 38753450
[TBL] [Abstract][Full Text] [Related]
9. Metformin induces apoptosis of melanoma B16 cells via PI3K/Akt/mTOR signaling pathways.
Tian Y; Zhao L
J BUON; 2020; 25(4):2066-2070. PubMed ID: 33099954
[TBL] [Abstract][Full Text] [Related]
10. High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells.
Varghese S; Samuel SM; Varghese E; Kubatka P; Büsselberg D
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30626087
[TBL] [Abstract][Full Text] [Related]
11. Ikaros 6 protects acute lymphoblastic leukemia cells against daunorubicin-induced apoptosis by activating the Akt-FoxO1 pathway.
Han J; Jin R; Zhang M; Guo Q; Zhou F
J Leukoc Biol; 2017 Mar; 101(3):675-681. PubMed ID: 27707884
[TBL] [Abstract][Full Text] [Related]
12. Oridonin in combination with imatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN/mTOR signaling pathway.
Guo Y; Shan Q; Gong Y; Lin J; Yang X; Zhou R
Cancer Biol Ther; 2012 Nov; 13(13):1244-54. PubMed ID: 22895079
[TBL] [Abstract][Full Text] [Related]
13. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
Li C; Liu VW; Chan DW; Yao KM; Ngan HY
Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.
Jiang G; Dallas-Yang Q; Biswas S; Li Z; Zhang BB
Biochem J; 2004 Jan; 377(Pt 2):339-46. PubMed ID: 14556646
[TBL] [Abstract][Full Text] [Related]
15. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
Triplitt C; Glass L; Miyazaki Y; Wajcberg E; Gastaldelli A; De Filippis E; Cersosimo E; DeFronzo RA
Diabetes Care; 2006 Nov; 29(11):2371-7. PubMed ID: 17065670
[TBL] [Abstract][Full Text] [Related]
16. Increased Th17 cells and IL-17A exist in patients with B cell acute lymphoblastic leukemia and promote proliferation and resistance to daunorubicin through activation of Akt signaling.
Bi L; Wu J; Ye A; Wu J; Yu K; Zhang S; Han Y
J Transl Med; 2016 May; 14(1):132. PubMed ID: 27176825
[TBL] [Abstract][Full Text] [Related]
17. EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway.
Huang R; Liu H; Chen Y; He Y; Kang Q; Tu S; He Y; Zhou X; Wang L; Yang J; Wu A; Li Y
Oncol Rep; 2018 Jan; 39(1):119-128. PubMed ID: 29192326
[TBL] [Abstract][Full Text] [Related]
18. Idarubicin induces mTOR-dependent cytotoxic autophagy in leukemic cells.
Ristic B; Bosnjak M; Arsikin K; Mircic A; Suzin-Zivkovic V; Bogdanovic A; Perovic V; Martinovic T; Kravic-Stevovic T; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L
Exp Cell Res; 2014 Aug; 326(1):90-102. PubMed ID: 24907655
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
[TBL] [Abstract][Full Text] [Related]
20. The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients: response to Poulsen et al.
Mikhail N
Diabetes Care; 2004 Jul; 27(7):1846-7; author reply 1847-8. PubMed ID: 15220287
[No Abstract] [Full Text] [Related]
[Next] [New Search]
